Kwan Ka Yu Carissa, Li Ke, Wang Yu Yang, Tse Wai Yi, Tong Chung Yan, Zhang Xu, Wang Dan Michelle, Ker Dai Fei Elmer
School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Bioengineering (Basel). 2025 May 19;12(5):546. doi: 10.3390/bioengineering12050546.
Developing fibrochondrogenic serum-free media is important for regenerating diseased and injured fibrocartilage but no defined protocols exist. Towards this goal, we characterized the effect of four candidate fibrochondrogenic serum-free media containing transforming growth factor beta-3 (TGF-β3), insulin-like growth factor-1 (IGF-1), and fibroblast growth factor-2 (FGF-2) with high/low glucose and with/without dexamethasone on human mesenchymal stem cells (hMSCs) via proliferation and differentiation assays. In Ki67 proliferation assays, serum-free media containing low glucose and dexamethasone exhibited the highest growth. In gene expression assays, serum-free media containing low glucose and commercially available chondrogenic media (COM) induced high fibrochondrogenic transcription factor expression (scleraxis/ and SRY-Box Transcription Factor 9/) and extracellular matrix (ECM) protein levels (aggrecan/ collagen type I/, and collagen type II/), respectively. In immunofluorescence staining, serum-free media containing high glucose and COM induced high fibrochondrogenic transcription factor (SCX and SOX9) and ECM protein (COL1A1, COL2A1, and collagen type X/COL10A1) levels, respectively. In cytochemical staining, COM and serum-free media containing dexamethasone showed a high collagen content whereas serum-free media containing high glucose and dexamethasone exhibited high glycosaminoglycan (GAG) levels. Altogether, defined serum-free media containing high glucose exhibited the highest fibrochondrogenic potential. In summary, this work studied conditions conducive for fibrochondrogenesis, which may be further optimized for potential applications in fibrocartilage tissue engineering.
开发无血清纤维软骨生成培养基对于患病和受伤纤维软骨的再生很重要,但目前尚无明确的方案。为了实现这一目标,我们通过增殖和分化试验,对四种含有转化生长因子β-3(TGF-β3)、胰岛素样生长因子-1(IGF-1)和成纤维细胞生长因子-2(FGF-2)的无血清纤维软骨生成候选培养基进行了表征,这些培养基分别含有高/低糖以及有/无地塞米松,用于培养人间充质干细胞(hMSCs)。在Ki67增殖试验中,含低糖和地塞米松的无血清培养基生长最快。在基因表达试验中,含低糖的无血清培养基和市售软骨生成培养基(COM)分别诱导了高纤维软骨生成转录因子表达(硬骨素/和SRY盒转录因子9/)和细胞外基质(ECM)蛋白水平(聚集蛋白聚糖/Ⅰ型胶原/和Ⅱ型胶原/)。在免疫荧光染色中,含高糖和COM的无血清培养基分别诱导了高纤维软骨生成转录因子(SCX和SOX9)和ECM蛋白(COL1A1、COL2A1和Ⅹ型胶原/COL10A1)水平。在细胞化学染色中,COM和含地塞米松的无血清培养基显示出高胶原含量,而含高糖和地塞米松的无血清培养基则表现出高糖胺聚糖(GAG)水平。总之,含高糖的无血清培养基表现出最高的纤维软骨生成潜力。综上所述,本研究探讨了有利于纤维软骨生成的条件,可为纤维软骨组织工程的潜在应用进一步优化。